UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 445

Sortiert nach

Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab

Cancer Immunology, Immunotherapy, 2021-11, Vol.70 (11), p.3199-3206

2021

Volltextzugriff (PDF)

Incidence and risk of hypertension with a novel multi‐targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta‐analysis

British journal of clinical pharmacology, 2013-09, Vol.76 (3), p.348-357

2013

Volltextzugriff (PDF)

Dual HER2 blockade therapy increases the risk of developing cardiac toxicities in HER2‐positive breast cancer: An up‐to‐date comprehensive meta‐analysis

The breast journal, 2021-01, Vol.27 (1), p.69-71

2021

Volltextzugriff (PDF)

Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta‐analysis of 36 clinical trials

British journal of clinical pharmacology, 2014-10, Vol.78 (4), p.748-762

2014

Volltextzugriff (PDF)

How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients?

Annals of surgical oncology, 2021-04, Vol.28 (4), p.2155-2168

2021

Volltextzugriff (PDF)

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of locally advanced esophageal cancer: a population-based analysis

International journal of clinical oncology, 2022-02, Vol.27 (2), p.340-347

2022

Volltextzugriff (PDF)

Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials

International journal of clinical oncology, 2014-04, Vol.19 (2), p.403-410

2014

Volltextzugriff (PDF)

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort

Thoracic cancer, 2023-06, Vol.14 (17), p.1556-1566

2023

Volltextzugriff (PDF)

Risk factors for developing cardiac toxicities in cancer patients treated with panitumumab combination therapy

Future oncology (London, England), 2020-07, Vol.16 (19), p.1359-1370

2020

Volltextzugriff (PDF)

Ki-67 Index Provides Long-Term Survival Information for Early-Stage HER2-Low-Positive Breast Cancer: A Single-Institute Retrospective Analysis

Journal of oncology, 2022-09, Vol.2022, p.1-9

2022

Volltextzugriff (PDF)

Epidemiology and prognosis of lymphoepithelioma-like carcinoma: a comprehensive analysis of surveillance, epidemiology, and end results (SEER) database

International journal of clinical oncology, 2021-07, Vol.26 (7), p.1203-1211

2021

Volltextzugriff (PDF)

IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer

BMC cancer, 2022-12, Vol.22 (1), p.1356-1356, Article 1356

2022

Volltextzugriff (PDF)

Risk factors for developing osteonecrosis of jaw in advanced cancer patients underwent zoledronic acid treatment

Future oncology (London, England), 2019-10, Vol.15 (30), p.3503-3511

2019

Volltextzugriff (PDF)

Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study

Cancer medicine (Malden, MA), 2023-06, Vol.12 (12), p.13309-13318

2023

Volltextzugriff (PDF)

The optimal regional irradiation volume for breast cancer patients: A comprehensive systematic review and network meta-analysis of published studies

Frontiers in oncology, 2023-01, Vol.13, p.1081201-1081201

2023

Volltextzugriff (PDF)

Risk of venous thromboembolic events associated with VEGFR‐TKIs: A systematic review and meta‐analysis

International journal of cancer, 2013-06, Vol.132 (12), p.2967-2974

2013

Volltextzugriff (PDF)

Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials

Breast (Edinburgh), 2020-02, Vol.49, p.165-170

2020

Volltextzugriff (PDF)

The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients

Breast (Edinburgh), 2023-04, Vol.68, p.142-148

2023

Volltextzugriff (PDF)

Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta‐analysis of clinical trials

British journal of clinical pharmacology, 2013-04, Vol.75 (4), p.919-930

2013

Volltextzugriff (PDF)

Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial

BMJ open, 2022-09, Vol.12 (9), p.e062034

2022

Volltextzugriff (PDF)

Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy

Radiation oncology (London, England), 2019-07, Vol.14 (1), p.128-128, Article 128

2019

Volltextzugriff (PDF)

No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis

Frontiers in oncology, 2022-09, Vol.12, p.897476-897476

2022

Volltextzugriff (PDF)

Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysis

PloS one, 2013-06, Vol.8 (6), p.e65166

2013

Volltextzugriff (PDF)

A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy

Drug design, development and therapy, 2022-01, Vol.16, p.2395-2406

2022

Volltextzugriff (PDF)

Simultaneous integrated boost for mediastinal lymph node recurrence after radical surgery for esophageal cancer: Interim results from a phase I/II prospective study

Thoracic cancer, 2021-04, Vol.12 (8), p.1180-1186

2021

Volltextzugriff (PDF)

1 – 25 von 445

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(374)
Mit Volltextzugriff
(405)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(321)
Life Sciences & Biomedicine
(206)
Humans
(132)
Technology
(75)
Oncology
(74)
Physical Sciences
(66)
Male
(65)
Female
(54)
Middle Aged
(48)
Meta-Analysis
(45)
Adult
(39)
Aged
(38)
Engineering
(37)
Materials Science
(37)
Cancer
(33)
Chemistry
(33)
Chemotherapy
(33)
Animals
(32)
Patients
(29)
Materials Science, Multidisciplinary
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab

Incidence and risk of hypertension with a novel multi‐targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta‐analysis

Dual HER2 blockade therapy increases the risk of developing cardiac toxicities in HER2‐positive breast cancer: An up‐to‐date comprehensive meta‐analysis

Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta‐analysis of 36 clinical trials

How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients?

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of locally advanced esophageal cancer: a population-based analysis

Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort

Risk factors for developing cardiac toxicities in cancer patients treated with panitumumab combination therapy

Ki-67 Index Provides Long-Term Survival Information for Early-Stage HER2-Low-Positive Breast Cancer: A Single-Institute Retrospective Analysis

Epidemiology and prognosis of lymphoepithelioma-like carcinoma: a comprehensive analysis of surveillance, epidemiology, and end results (SEER) database

IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer

Risk factors for developing osteonecrosis of jaw in advanced cancer patients underwent zoledronic acid treatment

Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study

The optimal regional irradiation volume for breast cancer patients: A comprehensive systematic review and network meta-analysis of published studies

Risk of venous thromboembolic events associated with VEGFR‐TKIs: A systematic review and meta‐analysis

Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials

The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients

Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta‐analysis of clinical trials

Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial

Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy

No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis

Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysis

A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy

Simultaneous integrated boost for mediastinal lymph node recurrence after radical surgery for esophageal cancer: Interim results from a phase I/II prospective study

Suchergebnisse filtern